Legal status CA: Schedule II PubChem CID 10091392 ChEMBL CHEMBL1209709 Molar mass 383.526 g/mol | CAS Number 639068-99-8 ChemSpider 8266929 Formula C23H33N3O2 | |
 | ||
Org 28611 (SCH-900,111) is a drug developed by Organon International which acts as a potent cannabinoid receptor full agonist at both the CB1 and CB2 receptors. It was developed with the aim of finding a water-soluble cannabinoid agonist suitable for intravenous use as an analgesic, and while it achieved this aim and has progressed as far as Phase II clinical trials in humans as both a sedative and an analgesic, results against the comparison drugs (midazolam and morphine respectively) were not particularly favourable in initial testing.
References
Org 28611 Wikipedia(Text) CC BY-SA